Where does Omega Ophthalmics LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Omega Ophthalmics LLC ranks #7,903 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Omega Ophthalmics LLC hold?

Omega Ophthalmics LLC holds 41 US utility patents granted between 2016 and 2025, spanning 2 technology areas.

What is Omega Ophthalmics LLC's Innovation Score?

Omega Ophthalmics LLC has an Innovation Score of 36.6 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Omega Ophthalmics LLC's patent grant rate increasing or decreasing?

Omega Ophthalmics LLC's recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Omega Ophthalmics LLC's patents?

Omega Ophthalmics LLC's patents average 19.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Omega Ophthalmics LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Omega Ophthalmics LLC

Q: What technology areas does Omega Ophthalmics LLC focus on?

Omega Ophthalmics LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 41 patents, ranking #150 of 3,082 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 41 granted patents across 2 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Omega ranks #7,903 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 2 technology areas.

#7,903
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.6/100): 19.1
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7903 · US Corporation #7,903 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 41 grants
UPPER-Q #7,903/49,997
PHOTO-FINISH NuVolta (Hefei)
CPC-NARROW A61F · 2 areas
INNOV-THIN 36.6/100
CLAIMS-RICH 19.1 claims/avg
TYPE-USCORP US Corporation
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: NuVolta Technologies (Hefei) Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Omega’s 36.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.9 pts (35%) Velocity 7.3 pts (20%) Breadth 5.0 pts (14%) Claim depth 11.4 pts (31%)

Qualcomm Incorporated · highest

85
Beijing Apollo Ding… · near

37
Constellation… · near

37
Lumenis · near

37
Omega Ophthalmics · this assignee

37
Relx · near

37
3D Lighting… · lowest

7

What this shows Omega's Innovation Score is 36.6/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Omega?

Each dot is one of Omega’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Omega’s own 19.1 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Omega vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Omega's grants concentrate

Omega Ophthalmics LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (7 grants) versus a trough of 2 in 2019. By volume, Omega sits between NuVolta Technologies (Hefei) Co., Ltd. and Polyphor AG.

Omega's three-year grant acceleration

Omega Ophthalmics LLC shows 12 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nuvolta (Hefei)

41
OL Security Liabi…

41
Oetiker NY

41
Oliver Crispin Ro…

41
Omicron

41
Outokumpu Oyj

41
Ovivo

41
Polyphor

41
Omega Ophthalmics ◀

41

What this shows Omega holds 41 patents at rank #7,903, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Omega

By rank, the assignees closest to #7,903 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Omega's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Omega, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Omega ranks #150 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Beijing Apollo Ding Rong Solar Technology Co., Ltd. 37 Constellation Pharmaceuticals, Inc. 37 Relx Inc. 37 Lumenis Ltd. 37

Omega's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Omega Ophthalmics LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	7	17.1%
2017	4	9.8%
2018	5	12.2%
2019	2	4.9%
2020	5	12.2%
2021	4	9.8%
2022	4	9.8%
2023	5	12.2%
2024	3	7.3%
2025partial year	2	4.9%

Which technologies does Omega Ophthalmics LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 41

A61B - DIAGNOSIS; SURGERY; Identification 5

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Omega Ophthalmics LLC's patent record in context - here's where to go next.

Omega Ophthalmics LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #7,903 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Omega Ophthalmics LLC against NuVolta Technologies (Hefei) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.